Neurocrine Bioscience buy Cantor Fitzgerald
Start price
10.04.24
/
50%
€129.55
Target price
10.04.25
€144.01
Performance (%)
-37.71%
End price
11.04.25
€80.70
Summary
This prediction ended on 11.04.25 with a price of €80.70. The BUY prediction by Cantor_Fitzgerald for Neurocrine Bioscience performed very badly with a performance of -37.71%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 1.665% | 1.665% | 5.957% |
| iShares Core DAX® | -3,99 % | -2,81 % | 4,16 % |
| iShares Nasdaq 100 | 0,35 % | -0,75 % | 9,47 % |
| iShares Nikkei 225® | -3,85 % | 4,23 % | 28,36 % |
| iShares S&P 500 | 0,30 % | 0,38 % | 6,14 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€110.65
16.09.24
16.09.24
€139.30
16.09.25
16.09.25
6.46%
17.09.25
17.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.40
29.08.24
29.08.24
€139.79
29.08.25
29.08.25
1.59%
30.08.25
30.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.10
25.07.24
25.07.24
€142.68
25.07.25
25.07.25
-17.38%
26.07.25
26.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€126.70
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24